These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28925392)

  • 1. Atypical E2Fs inhibit tumor angiogenesis.
    Weijts BGMW; Westendorp B; Hien BT; Martínez-López LM; Zijp M; Thurlings I; Thomas RE; Schulte-Merker S; Bakker WJ; de Bruin A
    Oncogene; 2018 Jan; 37(2):271-276. PubMed ID: 28925392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic functions of E2F7 and E2F8 are critical to suppress stress-induced skin cancer.
    Thurlings I; Martínez-López LM; Westendorp B; Zijp M; Kuiper R; Tooten P; Kent LN; Leone G; Vos HJ; Burgering B; de Bruin A
    Oncogene; 2017 Feb; 36(6):829-839. PubMed ID: 27452520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic role of E2F transcription factors in high-grade glioma.
    Yu H; Li Z; Wang M
    CNS Neurosci Ther; 2020 Jul; 26(7):741-753. PubMed ID: 32064771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chk1 and 14-3-3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest.
    Yuan R; Vos HR; van Es RM; Chen J; Burgering BM; Westendorp B; de Bruin A
    EMBO J; 2018 Mar; 37(5):. PubMed ID: 29363506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin F-dependent degradation of E2F7 is critical for DNA repair and G2-phase progression.
    Yuan R; Liu Q; Segeren HA; Yuniati L; Guardavaccaro D; Lebbink RJ; Westendorp B; de Bruin A
    EMBO J; 2019 Oct; 38(20):e101430. PubMed ID: 31475738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
    Moreno E; Toussaint MJM; van Essen SC; Bongiovanni L; van Liere EA; Koster MH; Yuan R; van Deursen JM; Westendorp B; de Bruin A
    Hepatology; 2021 Jan; 73(1):303-317. PubMed ID: 32259305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical E2Fs either Counteract or Cooperate with RB during Tumorigenesis Depending on Tissue Context.
    Moreno E; Pandit SK; Toussaint MJM; Bongiovanni L; Harkema L; van Essen SC; van Liere EA; Westendorp B; de Bruin A
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F8 is essential for polyploidization in mammalian cells.
    Pandit SK; Westendorp B; Nantasanti S; van Liere E; Tooten PC; Cornelissen PW; Toussaint MJ; Lamers WH; de Bruin A
    Nat Cell Biol; 2012 Nov; 14(11):1181-91. PubMed ID: 23064264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2f8 mediates tumor suppression in postnatal liver development.
    Kent LN; Rakijas JB; Pandit SK; Westendorp B; Chen HZ; Huntington JT; Tang X; Bae S; Srivastava A; Senapati S; Koivisto C; Martin CK; Cuitino MC; Perez M; Clouse JM; Chokshi V; Shinde N; Kladney R; Sun D; Perez-Castro A; Matondo RB; Nantasanti S; Mokry M; Huang K; Machiraju R; Fernandez S; Rosol TJ; Coppola V; Pohar KS; Pipas JM; Schmidt CR; de Bruin A; Leone G
    J Clin Invest; 2016 Aug; 126(8):2955-69. PubMed ID: 27454291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E2F7 and E2F8 keep the E2F family in balance.
    Moon NS; Dyson N
    Dev Cell; 2008 Jan; 14(1):1-3. PubMed ID: 18194644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression.
    Liu B; Shats I; Angus SP; Gatza ML; Nevins JR
    J Biol Chem; 2013 Aug; 288(34):24581-9. PubMed ID: 23853115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-damage response control of E2F7 and E2F8.
    Zalmas LP; Zhao X; Graham AL; Fisher R; Reilly C; Coutts AS; La Thangue NB
    EMBO Rep; 2008 Mar; 9(3):252-9. PubMed ID: 18202719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feedback regulation between atypical E2Fs and APC/CCdh1 coordinates cell cycle progression.
    Boekhout M; Yuan R; Wondergem AP; Segeren HA; van Liere EA; Awol N; Jansen I; Wolthuis RM; de Bruin A; Westendorp B
    EMBO Rep; 2016 Mar; 17(3):414-27. PubMed ID: 26882548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1.
    Weijts BG; Bakker WJ; Cornelissen PW; Liang KH; Schaftenaar FH; Westendorp B; de Wolf CA; Paciejewska M; Scheele CL; Kent L; Leone G; Schulte-Merker S; de Bruin A
    EMBO J; 2012 Oct; 31(19):3871-84. PubMed ID: 22903062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical E2fs control lymphangiogenesis through transcriptional regulation of Ccbe1 and Flt4.
    Weijts BG; van Impel A; Schulte-Merker S; de Bruin A
    PLoS One; 2013; 8(9):e73693. PubMed ID: 24069224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel E2F/sphingosine kinase 1 axis regulates anthracycline response in squamous cell carcinoma.
    Hazar-Rethinam M; de Long LM; Gannon OM; Topkas E; Boros S; Vargas AC; Dzienis M; Mukhopadhyay P; Simpson F; Endo-Munoz L; Saunders NA
    Clin Cancer Res; 2015 Jan; 21(2):417-27. PubMed ID: 25411162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion.
    Ubezio B; Blanco RA; Geudens I; Stanchi F; Mathivet T; Jones ML; Ragab A; Bentley K; Gerhardt H
    Elife; 2016 Apr; 5():. PubMed ID: 27074663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of E2F7 expression is an early event in squamous differentiation and causes derepression of the key differentiation activator Sp1.
    Hazar-Rethinam M; Cameron SR; Dahler AL; Endo-Munoz LB; Smith L; Rickwood D; Saunders NA
    J Invest Dermatol; 2011 May; 131(5):1077-84. PubMed ID: 21248772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
    Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
    Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.